ASTRAZEN
Invest with MTF
Invest Now
Invest in AstraZeneca Pharma India with 3.26X leverage
Performance
- Low
- ₹8,694
- High
- ₹8,950
- 52 Week Low
- ₹6,620
- 52 Week High
- ₹10,691
- Open Price₹8,800
- Previous Close₹8,674
- Volume6,519
- 50 DMA₹8,684.46
- 100 DMA₹8,790.84
- 200 DMA₹8,636.62
Investment Returns
- Over 1 Month + 7.3%
- Over 3 Month -1.42%
- Over 6 Month + 1.87%
- Over 1 Year + 17.56%
Smart Investing Starts Here Start SIP with AstraZeneca Pharma India for Steady Growth!
AstraZeneca Pharma India Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 111.6
- PEG Ratio
- 0.8
- Market Cap Cr
- 22,226
- P/B Ratio
- 27.8
- Average True Range
- 181.41
- EPS
- 92.47
- Dividend Yield
- 0.4
- MACD Signal
- -56.42
- RSI
- 55.72
- MFI
- 41.76
AstraZeneca Pharma India Financials
AstraZeneca Pharma India Technicals
EMA & SMA
Current Price
₹8,890.50
+
216.5
(2.5%)
- Bearish Moving Average 1
- Bullish Moving Average 15
- 20 Day
- ₹8,555.72
- 50 Day
- ₹8,684.46
- 100 Day
- ₹8,790.84
- 200 Day
- ₹8,636.62
Resistance and Support
8661.33
- R3 8,831.17
- R2 8,770.33
- R1 8,722.17
- S1 8,613.17
- S2 8,552.33
- S3 8,504.17
AstraZeneca Pharma India Corporate Actions - Bonus, Splits, Dividends
AstraZeneca Pharma India F&O
About AstraZeneca Pharma India
- NSE Symbol
- ASTRAZEN
- BSE Symbol
- 506820
- Managing Director
- Mr. Praveen Rao Akkinepally
- ISIN
- INE203A01020
Similar Stocks to AstraZeneca Pharma India
AstraZeneca Pharma India FAQs
AstraZeneca Pharma India share price is ₹8,890 As on 10 February, 2026 | 11:55
The Market Cap of AstraZeneca Pharma India is ₹22226.2 Cr As on 10 February, 2026 | 11:55
The P/E ratio of AstraZeneca Pharma India is 111.6 As on 10 February, 2026 | 11:55
The PB ratio of AstraZeneca Pharma India is 27.8 As on 10 February, 2026 | 11:55
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.